Episurf Medical AB will exhibit at the London Knee Meeting held in London, UK, on October 3
Episurf Medical (NASDAQ: EPIS B) will exhibit at the London Knee Meeting (recognized as one of the most important meetings in the orthopaedic calendar) held in London, UK (Queen Elizabeth II Conference Centre), on Tuesday October 3.
For full program, see http://www.londonkneemeeting.co.uk/ . For an overview of the industry conferences attended by Episurf Medical, see link. (www.episurf.com/healthcare-professionals/conferences).
For more information, please contact:
Pål Ryfors, CEO, Episurf Medical
Tel: +46 (0) 709 62 36 69
About Episurf Medical
Episurf Medical is endeavoring to bring people with painful joint injuries a more active, healthier life through the availability of minimally invasive and personalized treatment alternatives. Episurf Medical’s Episealer® personalized implants and Epiguide® surgical drill guides are developed for treating localized cartilage injury in joints. Episurf Medical’s μiFidelity® system enables implants to be cost-efficiently tailored to each individual’s unique injury for the optimal fit and minimal intervention. Episurf Medical’s head office is in Stockholm, Sweden. Its share (EPIS B) is listed on Nasdaq Stockholm. For more information, go to the company’s website: www.episurf.com.